Manufacturer of pharmaceutical products. The company develops and offers drugs used in the treatment of cancer patients suffering from neutropenia, a low white blood cell count as a result of chemotherapy treatment.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore Ribotech‘s full profile, request access.
© 2022 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.